Advanced search
1 file | 941.82 KB Add to list

Two-year toxicity of hypofractionated breast cancer radiotherapy in five fractions

Hans Van Hulle (UGent) , Vincent Vakaet (UGent) , Kathleen Deckmyn, Christel Monten (UGent) , Leen Paelinck (UGent) , Annick Van Greveling (UGent) , Giselle Post (UGent) , Max Schoepen (UGent) , Arthur Fonteyne, Bruno Speleers (UGent) , et al.
(2020) ACTA ONCOLOGICA. 59(7). p.872-875
Author
Organization
Keywords
Oncology, Radiology Nuclear Medicine and imaging, Hematology, General Medicine, INTENSITY-MODULATED RADIOTHERAPY, CONSERVING SURGERY, RADIATION-THERAPY, INTEGRATED BOOST, TRIAL, IRRADIATION, STANDARDIZATION, PATIENT, RISK

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 941.82 KB

Citation

Please use this url to cite or link to this publication:

MLA
Van Hulle, Hans, et al. “Two-Year Toxicity of Hypofractionated Breast Cancer Radiotherapy in Five Fractions.” ACTA ONCOLOGICA, vol. 59, no. 7, 2020, pp. 872–75, doi:10.1080/0284186x.2020.1747638.
APA
Van Hulle, H., Vakaet, V., Deckmyn, K., Monten, C., Paelinck, L., Van Greveling, A., … Veldeman, L. (2020). Two-year toxicity of hypofractionated breast cancer radiotherapy in five fractions. ACTA ONCOLOGICA, 59(7), 872–875. https://doi.org/10.1080/0284186x.2020.1747638
Chicago author-date
Van Hulle, Hans, Vincent Vakaet, Kathleen Deckmyn, Christel Monten, Leen Paelinck, Annick Van Greveling, Giselle Post, et al. 2020. “Two-Year Toxicity of Hypofractionated Breast Cancer Radiotherapy in Five Fractions.” ACTA ONCOLOGICA 59 (7): 872–75. https://doi.org/10.1080/0284186x.2020.1747638.
Chicago author-date (all authors)
Van Hulle, Hans, Vincent Vakaet, Kathleen Deckmyn, Christel Monten, Leen Paelinck, Annick Van Greveling, Giselle Post, Max Schoepen, Arthur Fonteyne, Bruno Speleers, Pieter Deseyne, Marcus Mareel, Wilfried De Neve, and Liv Veldeman. 2020. “Two-Year Toxicity of Hypofractionated Breast Cancer Radiotherapy in Five Fractions.” ACTA ONCOLOGICA 59 (7): 872–875. doi:10.1080/0284186x.2020.1747638.
Vancouver
1.
Van Hulle H, Vakaet V, Deckmyn K, Monten C, Paelinck L, Van Greveling A, et al. Two-year toxicity of hypofractionated breast cancer radiotherapy in five fractions. ACTA ONCOLOGICA. 2020;59(7):872–5.
IEEE
[1]
H. Van Hulle et al., “Two-year toxicity of hypofractionated breast cancer radiotherapy in five fractions,” ACTA ONCOLOGICA, vol. 59, no. 7, pp. 872–875, 2020.
@article{8671591,
  author       = {Van Hulle, Hans and Vakaet, Vincent and Deckmyn, Kathleen and Monten, Christel and Paelinck, Leen and Van Greveling, Annick and Post, Giselle and Schoepen, Max and Fonteyne, Arthur and Speleers, Bruno and Deseyne, Pieter and Mareel, Marcus and De Neve, Wilfried and Veldeman, Liv},
  issn         = {0284-186X},
  journal      = {ACTA ONCOLOGICA},
  keywords     = {Oncology,Radiology Nuclear Medicine and imaging,Hematology,General Medicine,INTENSITY-MODULATED RADIOTHERAPY,CONSERVING SURGERY,RADIATION-THERAPY,INTEGRATED BOOST,TRIAL,IRRADIATION,STANDARDIZATION,PATIENT,RISK},
  language     = {eng},
  number       = {7},
  pages        = {872--875},
  title        = {Two-year toxicity of hypofractionated breast cancer radiotherapy in five fractions},
  url          = {http://dx.doi.org/10.1080/0284186x.2020.1747638},
  volume       = {59},
  year         = {2020},
}

Altmetric
View in Altmetric
Web of Science
Times cited: